Head of Translational Medicine
Chris brings experience of more than 20 years working in Translational Medicine to his role as Head of TranScrip’s Translational Medicine team.
He has worked across several therapeutic areas, including cardiovascular, metabolic, CNS and inflammation. He has the breadth of knowledge afforded by working with both small molecules and biologicals. He has been responsible for integrating pre-clinical safety and toxicology findings into selecting doses for FIH studies in patients and healthy volunteers, and creating strategies for Proof of Concept and for PK/PD modelling to support rational dose selection in efficacy studies. He has wide experience in the review of in-licensing opportunities, and in all roles he has prepared regulatory documents and successfully defended safety, translational medicine and clinical pharmacology positions with regulatory agencies.